Brian E. Schultz
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in ⓘ
-
- Photosynthetic Processes and Mechanisms 5
- Signaling Pathways in Disease 3
- Protein Degradation and Inhibitors 3
- Oncology 7
- Peptidase Inhibition and Analysis 4
- Co-authors
- Sunney I. Chan (5 shared papers)R. H. Holm (5 shared papers)Peter R. Young (3 shared papers)Stacie A. Dalrymple (3 shared papers)Stephen F. Gheller (3 shared papers)Paul A. Sprengeler (3 shared papers)Douglas A. Jeffery (1 shared paper)James T. Palmer (1 shared paper)
- Journals
- Journal of the American Chemical Society (3 papers)Journal of Hepatology (3 papers)Molecular Cancer Therapeutics (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Brian E. Schultz
33 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Genetics 422
- Hematology 191
- Inorganic Chemistry 237
- Pathology and Forensic Medicine 266
- Oncology 379
Countries citing papers authored by Brian E. Schultz
This map shows the geographic impact of Brian E. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Schultz more than expected).
Fields of papers citing papers by Brian E. Schultz
This network shows the impact of papers produced by Brian E. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Schultz. The network helps show where Brian E. Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian E. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase Hit paper breakdown → | 2006 | 517 |
| 2 | 2001 | 201 | |
| 3 | 1993 | 139 | |
| 4 | 2015 | 119 | |
| 5 | 2006 | 97 | |
| 6 | 2017 | 76 | |
| 7 | 2019 | 75 | |
| 8 | 2020 | 74 | |
| 9 | 2004 | 72 | |
| 10 | 1995 | 71 | |
| 11 | 1993 | 65 | |
| 12 | 2015 | 62 | |
| 13 | 2020 | 41 | |
| 14 | 1992 | 37 | |
| 15 | 2006 | 25 | |
| 16 | 2015 | 22 | |
| 17 | 1997 | 22 | |
| 18 | 2000 | 20 | |
| 19 | THIP, isoguvacine, isoguvacine oxide, and related GABA agonists. | 1981 | 17 |
| 20 | 1998 | 14 |
About Brian E. Schultz
Brian E. Schultz is a scholar working on Molecular Biology, Oncology, Genetics, Radiology, Nuclear Medicine and Imaging and Inorganic Chemistry, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Photosynthetic Processes and Mechanisms (5 papers), Metalloenzymes and iron-sulfur proteins (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Hepatitis C virus research (4 papers), Signaling Pathways in Disease (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Genetics (422 citations), Hematology (191 citations), Inorganic Chemistry (237 citations), Pathology and Forensic Medicine (266 citations) and Oncology (379 citations). Brian E. Schultz has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Sunney I. Chan, R. H. Holm, Peter R. Young, Stacie A. Dalrymple, Stephen F. Gheller, Paul A. Sprengeler, Douglas A. Jeffery, James T. Palmer, Rohan Mendonca and Lee Honigberg. Their work appears in journals such as Journal of the American Chemical Society, Journal of Hepatology, Molecular Cancer Therapeutics, Antimicrobial Agents and Chemotherapy and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.